Ophthalmic products manufacturer Alcon Research has been hit with an untitled letter by the US Food and Drug Administration (FDA) regarding its Pataday allergy eye drops, which regulators claim were ...

Six years after being spun out from Novartis and becoming a public company, eye care specialist Alcon has gained its first FDA approval for a prescription drug, scoring a nod for dry eye disease (DED) ...

May 28 (Reuters) - (This May 28 story has been corrected to say 'eye drop,' not 'liquid medication,' in paragraph 3 and to remove the picture) Eye-care drugmaker Alcon (ALCC.S), opens new tab said on ...

Please provide your email address to receive an email when new articles are posted on . The TRPM8 receptor agonist increases natural tear production as early as day 1. Alcon also launched a campaign ...

Credit: Alcon. Access initiatives including a First Fill Free trial program and an ongoing copay support will be available for eligible patients. The active ingredient in Tryptyr is acoltremon, an ...

GENEVA--(BUSINESS WIRE)--Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the U.S. launch of SYSTANE ® PRO Preservative-Free (PF) as ...